Loading: 100%
Lantheus Holdings, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 465 (as per Q3 2016)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker LNTHno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1705101520
datesClosing price (adj.)
13.10.201717.85
11.10.201718.70
04.10.201717.90
27.09.201717.45
20.09.201717.25
13.09.201717.15
06.09.201716.40
30.08.201716.95
23.08.201716.70
16.08.201715.70
09.08.201718.50
02.08.201715.50
26.07.201719.20
19.07.201718.45
12.07.201718.33
05.07.201718.45
27.06.201716.15
20.06.201715.10
13.06.201715.95
06.06.201716.05
30.05.201716.50
23.05.201716.75
16.05.201716.40
09.05.201715.40
02.05.201712.90
25.04.201711.80
18.04.201711.50
11.04.201711.60
04.04.201712.30
28.03.201712.15
21.03.201711.80
14.03.201712.33
07.03.201713.10
28.02.201712.80
21.02.20179.35
14.02.20179.20
07.02.20179.05
31.01.20178.50
24.01.20178.65
17.01.20179.15
10.01.20178.75
03.01.20178.85
27.12.20168.45
19.12.20169.00
12.12.20169.35
05.12.20169.25
28.11.20169.60
21.11.20169.15
14.11.201610.20
07.11.20169.20
31.10.20168.65
24.10.20169.70
17.10.20168.45
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
17.85n/a
Market Capitalisation
in million USD
638n/a
Enterprise Value
in million USD
883n/a
Common Shares Outstanding
as per Oct 31, 2016
35,724,793n/a
Preferred Shares Outstanding
as per Oct 31, 2016
n/a
Average Basic Shares Outstanding
TTM
24,446,003,602n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 299n/a
Gross Profit 137n/a
Operating Income 50n/a
EBITDA 67n/a
Net Profit 26n/a
Balance Sheet
Cash and Cash Equivalents 53n/a
Receivables 35n/a
Total Current Assets 110n/a
PP&E 85n/a
Total Assets 255n/a
Accounts Payable 14n/a
Current Debt 4n/a
Total Current Liabilities 39n/a
Long-Term Debt 295n/a
Total Liabilities 376n/a
Total Equity -121n/a
Cash Flow
Depreciation & Amortisation 16n/a
Change in Working Capital 6n/a
Operating Cash Flow 49n/a
Net Change in PP&E and Intangibles -20n/a
Investing Cash Flow 1n/a
Dividends Paid 0n/a
Financing Cash Flow -19n/a
Total Change in Cash 30n/a
Free Cash Flow 51n/a
Profitability Ratios
Gross Margin 45.7%n/a
Operating Margin 16.9%n/a
Net Profit Margin 8.6%n/a
Return on Equity -21.3%n/a
Return on Assets 10.1%n/a
Per Share Figures
Basic EPS 0.00n/a
Diluted EPS n/a
Sales per Share 0.01n/a
Book Value per Share -0.01n/a
FCF per Share 0.00n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 16,907.33n/a
Price to Sales Ratio 1,460.85n/a
Price to Book Value -3,601.65n/a
Price to Free Cash Flow 8,599.94n/a
Valuation Metrics
EV/EBITDA 13.27n/a
EV/Sales 2.96n/a
Book to Market Value -0.19n/a
Other Ratios
Current Ratio 282.4%n/a
Liabilities to Equity Ratio -310.5%n/a
Debt to Assets Ratio 117.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Revenue
284
302
293
Sales & Services Revenue
0
0
0
Financing Revenue
0
0
0
Other Revenue
0
0
0
Cost of revenue
-206
-176
-158
Cost of Goods & Services
0
0
0
Cost of Financing Revenue
0
0
0
Cost of Other Revenue
0
0
0
Gross Profit
77
126
136
Other Operating Income
0
0
0
Operating Expenses
-99
-86
-93
Selling, General & Administrative
-68
-72
-79
Selling & Marketing
0
0
0
General & Administrative
0
0
0
Research & Development
-30
-14
-14
Depreciation & Amortization
0
0
0
Provision For Doubtful Accounts
0
0
0
Other Operating Expense
0
0
0
Operating Income (Loss)
-21
39
43
Non-Operating Income (Loss)
-42
-42
-39
Interest Expense, net
-43
-42
-39
Interest Expense
0
0
0
Interest Income
0
0
0
Other Investment Income (Loss)
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
Income (Loss) from Affiliates
0
0
0
Other Non-Operating Income (Loss)
1
0
0
Pretax Income (Loss), Adjusted
-63
-2
4
Abnormal Gains (Losses)
2
0
-16
Acquired In-Process R&D
0
0
0
Merger / Acquisition Expense
0
0
0
Abnormal Derivatives
0
0
0
Disposal of Assets
0
0
0
Early extinguishment of Debt
0
0
0
Asset Write-Down
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
Sale of Business
0
0
0
Legal Settlement
0
0
0
Restructuring Charges
0
0
0
Sale of and Unrealized Investments
0
0
0
Insurance Settlement
0
0
0
Other Abnormal Items
0
0
0
Pretax Income (Loss)
-61
-2
-12
Income Tax (Expense) Benefit, net
-1
-1
-3
Current Income Tax
0
0
0
Deferred Income Tax
0
0
0
Tax Allowance/Credit
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
Income (Loss) from Continuing Operations
-62
-4
-15
Net Extraordinary Gains (Losses)
0
0
0
Discontinued Operations
0
0
0
XO & Accounting Charges & Other
0
0
0
Income (Loss) Including Minority Interest
-62
-4
-15
Minority Interest
0
0
0
Net Income
-62
-4
-15
Preferred Dividends
0
0
0
Other Adjustments
0
0
0
Net Income Available to Common Shareholders
-62
-4
-15
Remarks
restated on Mar 2, 2016 n/a
calculated values,
restated on Mar 2, 2016 n/a
calculated values,
restated on Mar 2, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
20
29
Cash & Cash Equivalents
n/a
20
29
Short Term Investments
n/a
0
0
Accounts & Notes Receivable
n/a
42
37
Accounts Receivable, Net
n/a
42
37
Notes Receivable, Net
n/a
0
0
Unbilled Revenues
n/a
0
0
Inventories
n/a
16
16
Raw Materials
n/a
0
0
Work In Process
n/a
0
0
Finished Goods
n/a
0
0
Other Inventory
n/a
0
0
Other Short Term Assets
n/a
4
8
Prepaid Expenses
n/a
0
0
Derivative & Hedging Assets
n/a
0
0
Assets Held-for-Sale
n/a
0
5
Deferred Tax Assets
n/a
0
0
Income Taxes Receivable
n/a
0
0
Discontinued Operations
n/a
0
0
Miscellaneous Short Term Assets
n/a
4
4
Total Current Assets
n/a
81
90
Property, Plant & Equipment, Net
n/a
96
87
Property, Plant & Equipment
n/a
0
0
Accumulated Depreciation
n/a
0
0
Long Term Investments & Receivables
n/a
0
0
Long Term Investments
n/a
0
0
Long Term Marketable Securities
n/a
0
0
Long Term Receivables
n/a
0
0
Other Long Term Assets
n/a
66
66
Intangible Assets
n/a
30
30
Goodwill
n/a
16
16
Other Intangible Assets
n/a
0
0
Prepaid Expense
n/a
0
0
Deferred Tax Assets
n/a
0
0
Derivative & Hedging Assets
n/a
0
0
Prepaid Pension Costs
n/a
0
0
Discontinued Operations
n/a
0
0
Investments in Affiliates
n/a
0
0
Miscellaneous Long Term Assets
n/a
21
21
Total Noncurrent Assets
n/a
162
152
Total Assets
n/a
243
242
Liabilities and owners' equity
Payables & Accruals
n/a
41 40528000
30 30159000
Accounts Payable
n/a
16 15665000
12 11657000
Accrued Taxes
n/a
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
Other Payables & Accruals
n/a
25 24863000
19 18502000
Short Term Debt
n/a
0 0
4 3650000
Short Term Borrowings
n/a
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
Other Short Term Liabilities
n/a
8 8000000
2 1715000
Deferred Revenue
n/a
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
8 8000000
2 1715000
Total Current Liabilities
n/a
49 48528000
36 35524000
Long Term Debt
n/a
393 392863000
350 349858000
Long Term Borrowings
n/a
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
Other Long Term Liabilities
n/a
41 41032000
42 42286000
Accrued Liabilities
n/a
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
Pensions
n/a
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
41 41032000
42 42286000
Total Noncurrent Liabilities
n/a
434 433895000
392 392144000
Total Liabilities
n/a
482 482423000
428 427668000
Preferred Equity
n/a
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
107 106880000
176 175856000
Common Stock
n/a
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
Other Share Capital
n/a
0 0
0 0
Treasury Stock
n/a
0 -106000
0 0
Retained Earnings
n/a
-344 -344414000
-359 -359160000
Other Equity
n/a
-2 -1630000
-2 -1985000
Equity Before Minority Interest
n/a
-239 -239270000
-185 -185289000
Minority Interest
n/a
0 0
0 0
Total Equity
n/a
-239 -239270000
-185 -185289000
Total Liabilities & Equity
n/a
243 243153000
242 242379000
Remarks restated on n/a restated on Mar 2, 2016 n/a restated on Nov 1, 2016 n/a
Cash Flow StatementCF data quality: 91% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Net Income/Starting Line
-62
-4
-15
Net Income
0
0
0
Net Income From Discontinued Operations
0
0
0
Other Adjustments
0
0
0
Depreciation & Amortization
26
19
20
Non-Cash Items
32
8
24
Stock-Based Compensation
0
0
0
Deferred Income Taxes
0
0
0
Other Non-Cash Adjustments
0
0
0
Change in Working Capital
-12
-12
-7
(Increase) Decrease in Accounts Receivable
0
0
0
(Increase) Decrease in Inventories
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
Increase (Decrease) in Other
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
Cash from Operating Activities
-16
12
22
Change in Fixed Assets & Intangibles
-3
-8
-13
Disposition of Fixed Assets & Intangibles
0
0
0
Disposition of Fixed Assets
0
0
0
Disposition of Intangible Assets
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
Purchase of Fixed Assets
0
0
0
Acquisition of Intangible Assets
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
Net Change in Long Term Investment
0
0
0
Decrease in Long Term Investment
0
0
0
Increase in Long Term Investment
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
Net Cash from Divestitures
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
Cash for Joint Ventures
0
0
0
Net Cash from Other Acquisitions
0
0
0
Other Investing Activities
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
Cash from Investing Activities
-3
-8
-13
Dividends Paid
0
0
0
Cash From (Repayment of) Debt
7
0
8
Cash From (Repayment of) Short Term Debt, net
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
Repayments of Long Term Debt
0
0
0
Cash From Long Term Debt
0
0
0
Cash From (Repurchase of) Equity
0
0
0
Increase in Capital Stock
0
0
0
Decrease in Capital Stock
0
0
0
Other Financing Activities
-1
-2
-7
Net Cash From Discontinued Operations (financing)
0
0
0
Cash from Financing Activities
6
-2
1
Net Cash Before Disc. Operations and FX
-13
2
10
Change in Cash from Disc. Operations and Other
0
0
0
Net Cash Before FX
-13
2
10
Effect of Foreign Exchange Rates
-1
0
-1
Net Changes in Cash
-15
1
9
Remarks
restated on Mar 2, 2016 n/a
calculated values,
restated on Mar 2, 2016 n/a
calculated values,
restated on Mar 2, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo